Citation Impact
Citing Papers
The Role of Interleukin (IL)-10 in the Persistence of Leishmania major in the Skin after Healing and the Therapeutic Potential of Anti–IL-10 Receptor Antibody for Sterile Cure
2001
Plasmacytoid dendritic cells initiate a complex chemokine and cytokine network and are a viable drug target in chronic HCV patients
2007 StandoutNobel
Canine visceral leishmaniasis: a histopathological study of lymph nodes
2004
Development of a leishmaniasis vaccine: the importance of MPL
2003
CpG Oligodeoxynucleotides as Vaccine Adjuvants in Primates
2002
Quantitation of Simian Cytokine and β -Chemokine mRNAs, Using Real-Time Reverse Transcriptase-Polymerase Chain Reaction: Variations in Expression during Chronic Primate Lentivirus Infection
2002
Alternative Activation Is an Innate Response to Injury That Requires CD4+ T Cells to be Sustained during Chronic Infection
2007 StandoutNobel
IL-10: The Master Regulator of Immunity to Infection
2008 Standout
Diffuse and disseminated cutaneous leishmaniasis: clinical cases experienced in Ecuador and a brief review
2016
IRF-7 is the master regulator of type-I interferon-dependent immune responses
2005 StandoutNature
Leishmaniasis
2018 Standout
Leishmania/HIV co-infection in Brazil: an appraisal
2003
The Predictive Validity of Naturally Acquired Delayed‐Type Hypersensitivity to Leishmanin in Resistance toLeishmania major–Associated Cutaneous Leishmaniasis
2005
Diagnosis of canine visceral leishmaniasis: Biotechnological advances
2006
Population Genetics of Parasitic Protozoa and other Microorganisms
1995
Mechanisms of experimental resistance of Leishmania to miltefosine: Implications for clinical use
2006
Immunosuppressive networks in the tumour environment and their therapeutic relevance
2005 Standout
Domestic dog ownership: a risk factor for human infection with Leishmania (viannia) species
2003
Visceral leishmaniasis: what are the needs for diagnosis, treatment and control?
2007 Standout
Canine leishmaniosis – new concepts and insights on an expanding zoonosis: part one
2008 Standout
Immunotherapeutic uses of CpG oligodeoxynucleotides
2004
The Urban Spread of Visceral Leishmaniasis: Clues from Spatial Analysis
2002
Comparison of parasitological, immunological and molecular methods for the diagnosis of leishmaniasis in dogs with different clinical signs
2007
The biology and control of Phlebotomine sand flies
1999
Active immunization against cancer with dendritic cells: The near future
2001 StandoutNobel
Interleukin-12 and the regulation of innate resistance and adaptive immunity
2003 Standout
The immunology of susceptibility and resistance to Leishmania major in mice
2002 Standout
Long-lasting protection against canine visceral leishmaniasis using the LiESAp-MDP vaccine in endemic areas of France: Double-blind randomised efficacy field trial
2007
CD4+CD25+ regulatory T cells control Leishmania major persistence and immunity
2002 StandoutNature
CD4+CD25+ suppressor T cells: more questions than answers
2002 Standout
Leishmaniavaccines: progress and problems
2006
Treatment of cutaneous leishmaniasis among travellers
2004
The influence of the site of parasite inoculation on the development of Th1 and Th2 type immune responses in (BALB/c × C57BL/6) F1 mice infected with Leishmania major
1995
The Relationship of Leishmania braziliensis Subspecies and Immune Response to Disease Expression in New World Leishmaniasis
1989
Natural infection of Lutzomyia neivai with Leishmania spp. in northwestern argentina
2006 Standout
Genetic variability within the species Leishmania aethiopica does not correlate with clinical variations of cutaneous leishmaniasis
2000
Cutaneous leishmaniasis
2007 Standout
Cutaneous and mucocutaneous leishmaniasis
2009
Mini-exon gene variation in human pathogenic Leishmania species
1994
Immune response in healthy volunteers vaccinated with killed leishmanial promastigotes plus BCG. I: Skin-test reactivity, T-cell proliferation and interferon-γ production
1994
Second-generation vaccines against leishmaniasis
2005
Pentose phosphate metabolism in Leishmania mexicana
2003
Serum TSH, T4, and Thyroid Antibodies in the United States Population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III)
2002 Standout
Natural history, clinical evolution, and the host-parasite interaction in New World cutaneous leishmaniasis
1996
Mucosal leishmaniasis: in situ characterization of the host inflammatory response, before and after treatment
2002
Persistence ofLeishmaniaParasites in Scars after Clinical Cure of American Cutaneous Leishmaniasis: Is There a Sterile Cure?
2004
Effective clearance of intracellular Leishmania majorin vivo requires Pten in macrophages
2008 StandoutNobel
Histological and Immunohistochemical Study of Clinically Normal Skin of Leishmania infantum-infected Dogs
2003
Intestinal helminth coinfection is associated with mucosal lesions and poor response to therapy in American tegumentary leishmaniasis
2015
Functional Impairment of CD8+ T Cells by Regulatory T Cells during Persistent Retroviral Infection
2004 StandoutNobel
Synthetic Double-Stranded RNAs Are Adjuvants for the Induction of T Helper 1 and Humoral Immune Responses to Human Papillomavirus in Rhesus Macaques
2009 StandoutNobel
Parasite density and impaired biochemical/hematological status are associated with severe clinical aspects of canine visceral leishmaniasis
2005
Visceral Leishmaniasis in a New York Foxhound Kennel
2002
Successful treatment of cutaneous leishmaniasis with lipid formulations of amphotericin B in two immunocompromised patients
2004
Exploiting dendritic cells to improve vaccine efficacy
2002 StandoutNobel
The Regulation of Immunity to Leishmania Major
1995 Standout
Identification and diagnosis ofLeishmania mexicanacomplex isolates by polymerase chain reaction
1994
Cytotoxicity in human mucosal and cutaneous leishmaniasis
1995
Broadening horizons: the role of ferroptosis in cancer
2021 Standout
(1S,3S,7R)-3-methyl-α-himachalene from the male sandfly Lutzomyia longipalpis (Diptera: Psychodidae) induces neurophysiological responses and attracts both males and females
2005
Vaccines against intracellular infections requiring cellular immunity
2000 Nature
Leishmaniasis Worldwide and Global Estimates of Its Incidence
2012 Standout
Recombinant DNA-derived leishmania proteins: from the laboratory to the field
2005
Treatment of Bolivian Mucosal Leishmaniasis with Miltefosine
2007
Association of the Endobiont Double-Stranded RNA Virus LRV1 With Treatment Failure for Human Leishmaniasis Caused byLeishmania braziliensisin Peru and Bolivia
2015
Age-related changes in serum free thyroxine during childhood and adolescence
1993
Failure of a multi-subunit recombinant leishmanial vaccine (MML) to protect dogs from Leishmania infantum infection and to prevent disease progression in infected animals
2005
Clinical Spectrum of Leishmaniasis
1996
Safety, immunogenecity, and efficacy of an autoclaved Leishmania amazonensis vaccine plus BCG adjuvant against New World cutaneous leishmaniasis
2003
Spatial and Temporal Patterns of Phlebotomine Sand Flies (Diptera: Psychodidae) in a Cutaneous Leishmaniasis Focus in Northern Argentina
2004
Vaccines for parasitic and bacterial diseases
2003
Multifunctional TH1 cells define a correlate of vaccine-mediated protection against Leishmania major
2007 Standout
The pentose phosphate pathway and parasitic protozoa
1997
Antibody response in patients with cutaneous leishmaniasis infected by Leishmania (Viannia) braziliensis or Leishmania (Viannia) guyanensis in Brazil
2004
Haematogenous dissemination of Leishmania (Viannia) braziliensis in human American tegumentary leishmaniasis
2006
New use of BCG for recombinant vaccines
1991 StandoutNature
A killed Leishmania vaccine with sand fly saliva extract and saponin adjuvant displays immunogenicity in dogs
2007
Serodiagnosis of Leishmaniasis
1995
CpG oligonucleotides induce strong humoral but only weak CD4+ T cell responses to protein antigens in rhesus macaques in vivo
2005 StandoutNobel
Infectivity of seropositive dogs, showing different clinical forms of leishmaniasis, to Lutzomyia longipalpis phlebotomine sand flies
2007
Macrophage Cytokines: Involvement in Immunity and Infectious Diseases
2014 Standout
Immunogenicity and efficacy of immunodeficiency virus-like particles pseudotyped with the G protein of vesicular stomatitis virus
2006 StandoutNobel
Leishmania model for microbial virulence: the relevance of parasite multiplication and pathoantigenicity
2003
Molecular epidemiology and diagnosis of Leishmania: what have we learnt from genome structure, dynamics and function?
2002
Recent advances in vaccines for leishmaniasis
2004
Control of Neglected Tropical Diseases
2007 Standout
Synthesis and leishmanicidal activities of 1-(4-X-phenyl)-N′-[(4-Y-phenyl)methylene]-1H-pyrazole-4-carbohydrazides
2005
Comparative study of cutaneous leishmaniasis in human immunodeficiency virus (HIV)-infected patients and non-HIV-infected patients in French Guiana
2004
Protective efficacy of a tandemly linked, multi-subunit recombinant leishmanial vaccine (Leish-111f) formulated in MPLS adjuvant
2002
Leishmaniasis
1999 Standout
Leishmune® vaccine: The newest tool for prevention and control of canine visceral leishmaniosis and its potential as a transmission-blocking vaccine
2006
Visceral Leishmaniasis in a New York Foxhound Kennel
2002
LeishMan Recommendations for Treatment of Cutaneous and Mucosal Leishmaniasis in Travelers, 2014
2013
Transforming growth factor-beta in human cutaneous leishmaniasis.
1995
COMPARISON OF GENERIC TO BRANDED PENTAVALENT ANTIMONY FOR TREATMENT OF NEW WORLD CUTANEOUS LEISHMANIASIS
2004
Exploiting dendritic cells to improve vaccine efficacy
2002 StandoutNobel
Major Surface Protease of Trypanosomatids: One Size Fits All?
2009
Culture-Independent Species Typing of Neotropical Leishmania for Clinical Validation of a PCR-Based Assay Targeting Heat Shock Protein 70 Genes
2004
The immunomodulatory factors of bloodfeeding arthropod saliva
2000
REGULATION OF IMMUNE RESPONSES BY TGF-β
1998 Standout
Exploiting dendritic cells to improve vaccine efficacy
2002 StandoutNobel
Natural Product Synthesis Using Multicomponent Reaction Strategies
2009 Standout
Detection of Leishmania braziliensis in human paraffin-embedded tissues from Tucumán, Argentina by polymerase chain reaction
2005
Therapy of Venezuelan patients with severe mucocutaneous or early lesions of diffuse cutaneous leishmaniasis with a vaccine containing pasteurized Leishmania promastigotes and bacillus Calmette-Guerin: preliminary report
2004
SPECIES ASSIGNATION OF LEISHMANIA FROM HUMAN AND CANINE AMERICAN TEGUMENTARY LEISHMANIASIS CASES BY MULTILOCUS ENZYME ELECTROPHORESIS IN NORTH ARGENTINA
2005
An integrated device for the rapid and sensitive detection of the influenza hemagglutinin
2019 StandoutNobel
Biological Activities of Hydrazone Derivatives
2007 Standout
Leishmania and human immunodeficiency virus coinfection: the first 10 years
1997
Molecular Diagnosis of Leishmaniasis: Current Status and Future Applications
2006
Interventions for American cutaneous and mucocutaneous leishmaniasis
2009
Forests and human health: assessing the evidence
2006
Predicting Geographic Variation in Cutaneous Leishmaniasis, Colombia
2004
Sandfly Maxadilan Exacerbates Infection withLeishmania majorand Vaccinating Against It Protects AgainstL. majorInfection
2001
Human and Animal Dirofilariasis: the Emergence of a Zoonotic Mosaic
2012 Standout
IMMUNOTHERAPY VERSUS CHEMOTHERAPY IN LOCALISED CUTANEOUS LEISHMANIASIS
1987
Espacialização da leishmaniose tegumentar na cidade do Rio de Janeiro
2002 Standout
Dirofilaríase pulmonar humana no Estado do Rio de Janeiro, Brasil: relato de um caso
2004
Activation of Natural Killer T Cells by α-Galactosylceramide Rapidly Induces the Full Maturation of Dendritic Cells In Vivo and Thereby Acts as an Adjuvant for Combined CD4 and CD8 T Cell Immunity to a Coadministered Protein
2003 StandoutNobel
Vaccination with Plasmid DNA Encoding TSA/LmSTI1 Leishmanial Fusion Proteins Confers Protection againstLeishmania majorInfection in Susceptible BALB/c Mice
2002
Therapeutic Glucocorticoid-Induced TNF Receptor-Mediated Amplification of CD4+ T Cell Responses Enhances Antiparasitic Immunity
2010 StandoutNobel
Frequency of Infection of Lutzomyia Phlebotomines with Leishmania braziliensis in a Brazilian Endemic Area as Assessed by Pinpoint Capture and Polymerase Chain Reaction
2002
Cytokine profile and pathology in human leishmaniasis
1998
Intralesional therapy of American cutaneous leishmaniasis with pentavalent antimony in Rio de Janeiro, Brazil – an area of Leishmania (V.) braziliensis transmission
1997
The Use of Push-Pull Strategies in Integrated Pest Management
2006 Standout
Human cutaneous leishmaniasis caused by Leishmania (Viannia) braziliensis in Santiago del Estero, Argentina: identification of parasites by monoclonal antibodies and isoenzymes
1996
Mucosal leishmaniasis: A Retrospective Study of 327 Cases from an Endemic Area of Leishmania (Viannia) braziliensis
2017
Advances in leishmaniasis
2005 Standout
Assessment of Leishmaniasis notification system in Santiago del Estero, Argentina, 1990-1993.
2001
Epidemiology and Control of Neosporosis andNeospora caninum
2007 Standout
Human Leishmaniasis: Clinical, Diagnostic, and Chemotherapeutic Developments in the Last 10 Years
1997
PD-L1 and PD-L2 are differentially regulated by Th1 and Th2 cells
2003 StandoutNobel
Polymorphism in tumor necrosis factor genes associated with mucocutaneous leishmaniasis.
1995 Standout
In Vivo Targeting of Antigens to Maturing Dendritic Cells via the DEC-205 Receptor Improves T Cell Vaccination
2004 StandoutNobel
FAMILIAL AGGREGATION OF MUCOSAL LEISHMANIASIS IN NORTHEAST BRAZIL
2005
Study of the safety, immunogenicity and efficacy of attenuated and killed Leishmania (Leishmania) major vaccines in a rhesus monkey (Macaca mulatta) model of the human disease
2002
Protection against experimental visceral leishmaniasis infection in dogs immunized with purified excreted secreted antigens of Leishmania infantum promastigotes
2004
The Strange Case of Leishmania chagasi
2000
Fibroblasts as Host Cells in Latent Leishmaniosis
2000
MURINE CUTANEOUS LEISHMANIASIS: RESISTANCE IN RECONSTITUTED NUDE MICE AND SEVERAL F1 HYBRIDS INFECTED WITH LEISHMANIA TROPICA MAJOR
1983
COMPARATIVE EVALUATION OF ELISAS BASED ON TEN RECOMBINANT OR PURIFIED LEISHMANIA ANTIGENS FOR THE SERODIAGNOSIS OF MEDITERRANEAN VISCERAL LEISHMANIASIS
2003
Antileishmanial activity of compounds extracted and characterized from Centrolobium sclerophyllum
1998
Nature and Health
2014 Standout
Diagnosis and Treatment of Leishmaniasis: Clinical Practice Guidelines by the Infectious Diseases Society of America (IDSA) and the American Society of Tropical Medicine and Hygiene (ASTMH)
2016
The return of metabolism: biochemistry and physiology of the pentose phosphate pathway
2014 Standout
Phlebotominae fauna in the Province of Tucumán, Argentina
2002
The epidemiology and control of leishmaniasis in Andean countries
2000
Vaccination with Heat-killed Leishmania Antigen or Recombinant Leishmanial Protein and CpG Oligodeoxynucleotides Induces Long-Term Memory CD4+and CD8+T Cell Responses and Protection Against Leishmania major Infection
2002
Deltamethrin-impregnated dog collars have a potent anti-feeding and insecticidal effect on Lutzomyia longipalpis and Lutzomyia migonei
2001
Drug Resistance in Leishmaniasis
2006 Standout
Mucosal leishmaniasis (“spundia” Escomel, 1911)
1986
American Cutaneous and Mucocutaneous Leishmaniasis (Tegumentary): A Diagnostic Challenge
1992
Cysteine Protease B of Leishmania mexicana Inhibits Host Th1 Responses and Protective Immunity
2003
A stacking flow immunoassay for the detection of dengue-specific immunoglobulins in salivary fluid
2015
Works of Gabriel Grimaldi being referenced
Evaluation of a novel chromatographic immunoassay based on Dual-Path Platform technology (DPP® CVL rapid test) for the serodiagnosis of canine visceral leishmaniasis
2011
Leishmania amazonensis:The Asian Rhesus Macaques (Macaca mulatta) as an Experimental Model for Study of Cutaneous Leishmaniasis
1996
Detection ofLeishmaniaDNA by Polymerase Chain Reaction in Scars of Treated Human Patients
1998
Epidemiological studies on American leishmaniasis in Cearé State, Brazil
1988
Etiology of human cutaneous leishmaniasis in Nicaragua
1991
Identification, Using Isoenzyme Electrophoresis and Monoclonal Antibodies, of Leishmania Isolated from Humans and Wild Animals of Ecuador
1989
A Revised Classification for Leishmania and Endotrypanum
2000
Intergenic region typing (IRT): A rapid molecular approach to the characterization and evolution of Leishmania
1995
A Review of the Geographic Distribution and Epidemiology of Leishmaniasis in the New World
1989
Cutaneous leishmaniasis in western Venezuela caused by infection with Leishmania venezuelensis and L. braziliensis variants
1992
Molecular and biologic characterization of Leishmania parasites implicated in an epidemic outbreak in northwestern Argentina
2000
Antigenic differences of Leishmania amazonensis isolates causing diffuse cutaneous leishmaniasis
1990
Population heterogeneity among clones of New World Leishmania species
1990
DISSEMINATED AMERICAN CUTANEOUS LEISHMANIASIS
1996
Recent advances in the taxonomy of the New World leishmanial parasites
2001
Andean Leishmaniasis in Ecuador caused by Infection with Leishmania Mexicana and L. Major-Like Parasites
1991
Subspecies- and species-specific antigens of Leishmania mexicana characterized by monoclonal antibodies.
1985
Leishmania mexicana amazonensis isolated from a patient with fatal mucosal leishmaniasis
1985
Comparative Evaluation of Enzyme-Linked Immunosorbent Assays Based on Crude and Recombinant Leishmanial Antigens for Serodiagnosis of Symptomatic and Asymptomatic Leishmania infantum Visceral Infections in Dogs
2007
Intralesional plasma cells and serological responses in human cutaneous leishmaniasis.
1982
Tissue eosinophilia and Leishmania mexicana mexicana eosinophil interactions in murine cutaneous leishmaniasis
1984
Active cutaneous leishmaniasis in Brazil, induced by Leishmania donovani chagasi
1986
Genetic Polymorphism and Molecular Epidemiology ofLeishmania(Viannia)braziliensisfrom Different Hosts and Geographic Areas in Brazil
2003
Epidemiological and clinical features of Leishmania (Viannia) braziliensis American cutaneous and mucocutaneous leishmaniasis in the State of Espírito Santo, Brazil
2003
Host factors influencing outcome of Leishmania mexicana infection in mice
1983
Discrimination ofLeishmaniaisolates using a limited set of enzymatic loci
1995
Genetic Diversity in Natural Populations of New World Leishmania
1998
Mucosal leishmaniasis ("espundia") responsive to low dose of N-methyl glucamine (Glucantime ®) in Rio de Janeiro, Brazil
2000
Protection against Cutaneous Leishmaniasis Induced by Recombinant Antigens in Murine and Nonhuman Primate Models of the Human Disease
2001
Leishmaniases of the New World: current concepts and implications for future research
1993
Leishmania infantum, the aetiological agent of american visceral Leishmaniasis (AVL)?
1987
Leishmania mexicana: Immunology and histopathology in C3H mice
1980
Twenty-four hour profile of integrated TSH concentration in puberty
1981
Leishmania (Leishmania) major-infected rhesus macaques (Macaca mulatta) develop varying levels of resistance against homologous re-infections
2001
Production and characterization of species-specific monoclonal antibodies against Leishmania donovani for immunodiagnosis.
1984
Identification and Distribution of New World Leishmania Species Characterized by Serodeme Analysis Using Monoclonal Antibodies
1987
Disseminated American cutaneous leishmaniasis in a patient with AIDS
1987